Filter News
Area of Research
- (-) Computational Biology (2)
- (-) Isotopes (6)
- Advanced Manufacturing (2)
- Biological Systems (2)
- Biology and Environment (97)
- Biology and Soft Matter (1)
- Clean Energy (52)
- Climate and Environmental Systems (2)
- Computational Engineering (2)
- Computer Science (1)
- Fusion and Fission (24)
- Fusion Energy (13)
- Materials (30)
- Materials for Computing (4)
- Mathematics (1)
- National Security (11)
- Neutron Science (21)
- Nuclear Science and Technology (11)
- Quantum information Science (1)
- Supercomputing (72)
News Topics
- (-) Biomedical (7)
- (-) Climate Change (1)
- (-) Summit (1)
- Artificial Intelligence (1)
- Biology (2)
- Computer Science (2)
- Coronavirus (1)
- Energy Storage (1)
- Environment (1)
- High-Performance Computing (2)
- Irradiation (1)
- Isotopes (24)
- Materials (4)
- Materials Science (2)
- National Security (1)
- Neutron Science (1)
- Nuclear Energy (3)
- Security (1)
- Space Exploration (4)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.